LGR5 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesFEX; HG38; GPR49; GPR67; GRP49
ProductOrderL
Clone#2B5B9
Entrez GenelD8549
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG2b
ImmunogenPurified recombinant fragment of human LGR5 (AA: 22-178) expressed in E. Coli.
MW100kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
FCM (Flow Cytometry)1/200 - 1/400
WB (Western Blot)1/500 - 1/2000
Sequence
22-178
Catalog#: 30878
Inquire
Contact us to order
Images
Elisa
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Western Blot
Figure 2:Western blot analysis using LGR5 mAb against human LGR5 (AA: 22-178) recombinant protein. (Expected MW is 43.4 kDa)
Figure 2:Western blot analysis using LGR5 mAb against human LGR5 (AA: 22-178) recombinant protein. (Expected MW is 43.4 kDa)
Western Blot
Figure 3:Western blot analysis using LGR5 mAb against HEK293 (1) and LGR5 (AA: 22-178)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3:Western blot analysis using LGR5 mAb against HEK293 (1) and LGR5 (AA: 22-178)-hIgGFc transfected HEK293 (2) cell lysate.
Flow cytometric
Figure 4:Flow cytometric analysis of A549 cells using LGR5 mouse mAb (green) and negative control (red).
Figure 4:Flow cytometric analysis of A549 cells using LGR5 mouse mAb (green) and negative control (red).
Product Overview
DescriptionLGR5 (Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5) is a Protein Coding gene. Among its related pathways are Wnt signaling pathway (KEGG). GO annotations related to this gene include G-protein coupled receptor activity and transmembrane signaling receptor activity. An important paralog of this gene is LGR6.
References (references)
References (references)1.Tumour Biol. 2014 Nov;35(11):11605-12.
2.Int J Mol Med. 2014 Jul;34(1):35-42.